Both holmium laser enucleation of the prostate (HoLEP) and photoselective laser vaporisation of the prostate (PVP) are comparably safe and effective as treatments for benign prostatic hyperplasia (BPH). However, data from a prospective randomised trial suggests that the long-term outcomes of HoLEP surgery may be better.
Dr Yan-Bo Chen (Shanghai Jiao Tong University, China) presented a study that directly compared 2 different laser systems which each produce different qualitative and quantitative effects in tissue . The primary outcome was perioperative safety and 24-month follow-up efficacy data.
A total of 314 BPH patients (estimated prostate volume <60 mL, urodynamics-confirmed BPH) were randomly assigned 1:1 to receive either HoLEP or PVP. Operating times were longer for the patients receiving HoLEP (median 52.3±12.2 minutes) compared with PVP (46.6±12.0 min...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« LUTS 2-year outcomes: aquablation versus TURP Next Article
LUTS in the neuro-urologic patient »
Table of Contents: EAU 2020
Surgical Techniques and Safety
Prostate Cancer & Imaging
BPH & LUTS
Testis Cancer & Andrology
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.